W/W-v mice result in low bone mass. However, these mice are sterile and it is unclear whether the observed skeletal phenotype is secondary to a sex hormone deficiency. In contrast, C57BL/6J-Kit c-Kit, a receptor tyrosine kinase belonging to the platelet-derived growth factor (PDGF) and the colony-stimulating factor 1 (CSF-1) receptor family, is a product of the gene at the Dominant White Spotting (W) locus 1,2 . The ligand for c-Kit is the gene product of the Steel (Sl) locus and is known as mast cell growth factor, stem cell factor, steel factor, and Kit ligand (KL) 3, 4 . c-Kit and KL are essential for normal development and maintenance of three stem cell populations: germ cells, neural crest-derived melanocytes, and hematopoietic stem cells. c-Kit is present in primordial germ cells, spermatogonia, primordial oocytes, growing oocytes, melanocytes 5 , mast cells 6 , and osteoclasts 7 . Homozygotes carrying mutations at the W and Sl loci are erythrocyte-and mast cell-deficient, infertile, and lack pigmented coats 8 . Several naturally occurring loss-of-function mutations of c-Kit have been identified in mice and humans. The W mutation is a null mutation causing deletion of the transmembrane domain of the c-Kit receptor, while W v is a point mutation in the kinase domain of the receptor resulting in impaired receptor activity 9 . Cells expressing the W v mutation do not respond to KL in proliferation and apoptosis assays, presumably due to the inability of the receptor to initiate signal transduction [10] [11] [12] . W-sash (W sh ), an allele of W, is an inversion mutation upstream of the c-Kit promoter region affecting a key regulatory element, resulting in cell-type-specific altered expression of the gene [13] [14] [15] [16] . The W sh mutation arises spontaneously from crossing two inbred strains of C3H/HeH and 101/H mice. The role of KL/c-Kit signaling in the regulation of bone metabolism has been studied in vitro and in vivo. The human osteoblast-like cell line Saos-2 expresses KL on its cell surface, whereas the osteoclast progenitor-like cell line FLG 29.1 expresses c-Kit 7 . Based on these studies, it was concluded that the c-Kit receptor mediates cell-to-cell interactions between osteoclasts and osteoblasts/stromal cells through membrane-bound KL. Previous studies have identified skeletal changes in Sl/Sl d mutants lacking the transmembrane form of KL but had normal c-Kit receptors 17 . Deletion of membrane-bound KL induces osteopenia. The negative bone balance observed in these mice was primarily due to increased osteoclast surface. It has been shown that 14-week-old female WBB6F1/J-Kit W/W-v (W/W v ) mice carrying a compound c-Kit mutation were osteopenic 18 . However, these mice
c-Kit, a receptor tyrosine kinase belonging to the platelet-derived growth factor (PDGF) and the colony-stimulating factor 1 (CSF-1) receptor family, is a product of the gene at the Dominant White Spotting (W) locus 1, 2 . The ligand for c-Kit is the gene product of the Steel (Sl) locus and is known as mast cell growth factor, stem cell factor, steel factor, and Kit ligand (KL) 3, 4 . c-Kit and KL are essential for normal development and maintenance of three stem cell populations: germ cells, neural crest-derived melanocytes, and hematopoietic stem cells. c-Kit is present in primordial germ cells, spermatogonia, primordial oocytes, growing oocytes, melanocytes 5 , mast cells 6 , and osteoclasts 7 . Homozygotes carrying mutations at the W and Sl loci are erythrocyte-and mast cell-deficient, infertile, and lack pigmented coats 8 . Several naturally occurring loss-of-function mutations of c-Kit have been identified in mice and humans. The W mutation is a null mutation causing deletion of the transmembrane domain of the c-Kit receptor, while W v is a point mutation in the kinase domain of the receptor resulting in impaired receptor activity 9 . Cells expressing the W v mutation do not respond to KL in proliferation and apoptosis assays, presumably due to the inability of the receptor to initiate signal transduction [10] [11] [12] . W-sash (W sh ), an allele of W, is an inversion mutation upstream of the c-Kit promoter region affecting a key regulatory element, resulting in cell-type-specific altered expression of the gene [13] [14] [15] [16] . The W sh mutation arises spontaneously from crossing two inbred strains of C3H/HeH and 101/H mice. The role of KL/c-Kit signaling in the regulation of bone metabolism has been studied in vitro and in vivo. The human osteoblast-like cell line Saos-2 expresses KL on its cell surface, whereas the osteoclast progenitor-like cell line FLG 29.1 expresses c-Kit 7 . Based on these studies, it was concluded that the c-Kit receptor mediates cell-to-cell interactions between osteoclasts and osteoblasts/stromal cells through membrane-bound KL. Previous studies have identified skeletal changes in Sl/Sl d mutants lacking the transmembrane form of KL but had normal c-Kit receptors 17 . Deletion of membrane-bound KL induces osteopenia. The negative bone balance observed in these mice was primarily due to increased osteoclast surface. It has been shown that 14- were infertile due to a lack of germ cells in the ovary and had reduced estrogen and progesterone levels, leading to increased FSH level 19 . It is unclear whether the observed skeletal phenotype in W/W v mice resulted from cell-autonomous effects in osteoclasts or was a consequence of changes in sex hormone levels. In the present study, we focused on the skeletal phenotype of C57BL/6J-Kit (Fig. 1B) . The cancellous bone was less dense and thinner in W/W v mice with decreased trabecular number and thickness and increased trabecular separation (data not shown). Bone formation was reduced due to a slight decrease in mineralizing surface per bone surface (p = 0.052) and a significant decrease in mineral apposition rate. Although osteoblast surface per bone surface was not changed in the mutants, osteoclast surface per bone surface was significantly increased. Therefore, the reduction in bone volume in the mutants was the result of decreased bone formation and increased bone resorption. As expected, W/W v mice had decreased serum P1NP and increased serum CTX, confirming uncoupled bone turnover (Fig. 1C) The body weight of the mutants and WT were similar (data not shown). μ CT analysis of the cortical bone indicated that c-Kit mutation resulted in a significant decrease in total cross sectional volume, cortical volume, and marrow volume at 6, but not 9 and 13 weeks of age ( Fig. 2A Table S3 ). Indices of bone formation; osteoblast surface per bone surface, osteoid surface per bone surface, osteoid volume per tissue volume, and osteoid thickness, were markedly increased at 6 weeks of age. A trend toward an increase in serum P1NP was also observed (Fig. 2C) . However, the skeletal phenotype was milder in older mice. There was no statistical significant difference between control and mutant mice in all indices of bone formation at 13 weeks of age. In contrast, osteoclast surface per bone surface was dramatically increased compared with age-matched controls in all age groups. As shown in Fig. 2C , increased bone resorption in the mutants was confirmed by increased serum CTX levels.
We then examined the skeletal phenotype of 6 weeks old female mice. Fig. 3A , qPCR indicated that c-Kit mutation increased the expression of several osteoblast marker genes in femora including osteocalcin, Osterix, ALP, type I collagen and Runx2. The mRNA levels of both RANKL and OPG were increased therefore the RANKL/OPG ratio was not significantly changed. Expression profiling of osteoclast target genes showed increased expression of M-CSF, c-Fms, NFATC1 and TRAP in 6-week-old (Fig. 4A ). c-Kit mutation reduced the c-Kit mRNA levels in BMM and osteoclasts by 43 and 35%, respectively, whereas the c-Kit mRNA level in osteoblasts was not altered.
Mutation of c-Kit increased osteoclast number in all age groups. We examined whether the increased number of osteoclasts in W sh /W sh mice was a cell-autonomous effect. Consistent with the increased in vivo bone resorption, TRAP staining showed increased osteoclast number in cultured BMM derived from W sh /W sh mice compared with WT ( Fig. 4B,C) , indicating an intrinsic role for c-Kit in osteoclast differentiation. To determine the effect of c-Kit on osteoclast resorbing ability, equal numbers of WT and mutant osteoclasts were cultured on dentin slices and the resorbed areas were quantified. No differences were observed in resorption between the mutant and WT cells (Fig. 4B) 
Mutation of c-Kit increases osteoblast progenitors and differentiation.
To determine whether the increased bone formation observed in growing W sh /W sh mice was due to enhanced osteoblast proliferation and/ or differentiation, we analyzed the proliferation and differentiation of calvarial osteoblasts in vitro. One-day-old pups were genotyped (Fig. 5A ). Osteoblasts derived from W sh /W sh mice had higher ALP activity and formed more mineralized bone nodules than those from WT controls (Fig. 5B) , whereas osteoblast proliferation, determined by BrdU labeling, was unchanged (data not shown). Because c-Kit expression was similar in W sh /W sh and WT osteoblasts, we hypothesized that an increase in the osteoblast precursor population contributed to increased osteoblast differentiation in W sh /W sh mice. To test this hypothesis, we analyzed the capability of calvarial osteoblasts derived from W sh /W sh mice and their WT littermates to form ALP-positive colony forming units (CFU-ALP) and CFU-osteoblasts (CFU-OB). We found that although CFU-ALP and CFU-OB were increased, the number of CFU-fibroblasts (CFU-F) was not changed in W sh /W sh osteoblasts compared with WT controls (Fig. 5C ). qPCR analysis of calvarial osteoblasts derived from W sh /W sh mice showed increased expression of the osteoblast marker genes osteocalcin, Bsp, and Dmp1 (Fig. 6A) Osteoclasts were generated on glass coverslips in the presence of M-CSF and RANKL and osteoclast differentiation was evaluated by TRAP staining (upper). Osteoclasts generated by co-culture with osteoblasts on collagen gel in media containing vitamin D 3 and PGE 2 were replated onto dentin slices and cultured for 48 h (lower more anabolic coupling factors (Fig. 7A) . We then determined the expression of the known osteoclast-derived coupling factor genes, Efnb2, Sphk1, Sphk2, BMP6, Sema4D, Cthrc1 and Wnt10b [21] [22] [23] [24] [25] [26] from W sh /W sh and WT osteoclasts using qPCR. As shown in Fig. 7B , c-Kit mutants increased their expression of Wnt10b but not that of Efnb2, Sphk1, Sphk2, BMP6, Sema4D, or Cthrc1. Confocal immunofluorescence analysis of osteoclasts revealed increased Wnt10b staining in W sh /W sh osteoclasts cultured on dentin slices (Fig. 7C) . Western blot analysis of osteoclast-conditioned media confirmed an increase in Wnt10b protein level in mutants (Fig. 7D) . Before blotting, the membranes were stained with Ponceau S for protein detection. We found that the protein levels were comparable between the W sh /W sh and WT conditioned medium. conditioned medium-induced increase in ALP activity and mineralization. Therefore, Wnt10b is the major coupling factor responsible for W sh /W sh osteoclast-mediated increase in bone formation.
Discussion
Our data suggest that c-Kit plays a crucial role in bone remodeling process. In the present study, we first examined the skeletal phenotype of W/W v mice that carry a c-Kit point mutation and are sterile. W/W v mutants had decreased cortical and cancellous bone volume. The reduction in cancellous bone volume was the result of a marked decrease in osteoblast surface and increase in osteoclast surface, indicating uncoupled bone turnover. To gain further insight into the precise role of c-Kit in bone metabolism, we used W sh /W sh mice that possess an inversion mutation upstream of the c-Kit region and are fertile. This c-Kit mutation, which reduced c-Kit expression in BMMs and osteoclasts but did not affect its expression in osteoblasts, resulted in osteopenia associated with increased bone formation and increased bone resorption in growing W sh /W sh mice. The skeletal phenotype was milder when animals were mature. The increased osteoclast number was a consequence of an increased RANKL/OPG ratio in osteoblasts. It appears that the alteration in the osteoclast-osteoblast coupling mechanism contributes to increased bone formation in W sh /W sh mice. Mutation of c-Kit stimulates Wnt10b secretion from osteoclasts that promotes osteoblast mineralization and subsequently bone formation. Blocking Wnt10b markedly inhibited the increased ALP activity and mineralization that were induced by W sh /W sh osteoclast conditioned medium.
Physiologically, c-Kit expression is tightly regulated and the reduction or loss of c-Kit activity by known mutations is associated with bone loss. Osteoclasts express c-Kit receptor on their cell membrane and respond to its ligand directly through cell-to-cell contact 7 or indirectly through paracrine factors. The skeletal phenotype of W/W v mice is subtle and these mice are infertile due to germ cell depletion. It has been reported that male W/W v mice have normal plasma testosterone levels but elevated FSH levels 27 . However, our data indicated that seminal vesicle weight, an index of androgen deficiency, decreased by 42% in W/W v mice. The serum testosterone was also decreased in these mice. Male hypogonadism increases the production of osteoclasts and osteoblasts, leading to an increase in cancellous bone turnover [28] [29] [30] 31, 32 . Our co-culture experiments using osteoblasts and osteoclasts also confirmed that the increased RANKL/OPG ratio in W sh /W sh osteoblasts was responsible for the increased osteoclast differentiation observed in vitro.
According to the osteoclast commitment and differentiation pathway, CD11b is expressed during the differentiation of mononuclear early progenitor cells to mature multinucleated osteoclasts. The expression is higher in mononuclear cells and low in mature osteoclasts. It has been reported that c-Fms is a major determinant in osteoclast differentiation 33, 34 The mechanism by which loss-of-function mutation of c-Kit led to osteopenia in W sh /W sh mice remains unclear. It has been reported that c-Kit mediates cell-to-cell interactions between osteoclasts and osteoblasts/ stromal cells through membrane bound KL 7 . Soluble KL, in concert with other factors, stimulates osteoclast formation and activity 35 . Gleevec, which inhibits c-Kit as well as c-Fms, c-Abl, and PDGF receptor 36, 37 , decreases osteoclast number in rodents 38 and inhibit osteoclast differentiation in vitro 39 . When used therapeutically to treat chronic myeloid leukemia, it sometimes induces secondary hyperparathyroidism with inconsistent reports of changes in bone formation and bone resorption 40, 41 . The extent to which the effects of Gleevec on bone are mediated by inhibition of c-Kit has not been determined. [42] [43] [44] . Mast cell deficiency is associated with low bone turnover, whereas excessive mast cell number induces bone loss 45 . Although the relationship between mast cells and osteoclasts is not completely understood, mast cells can modulate osteoclast activity through their release of granule-associated cytokines. However, it has been reported that mast cells are rarely found in mouse bone marrow 18, 46 . Therefore, it is unlikely that mast cells contribute to the skeletal changes observed in our study.
The role of c-Kit in bone formation remains undefined. Although it has been reported that c-Kit is expressed in primary rat osteoblasts and SaOS-2 cells but not MC3T3-E1, ST2 or RAW 264.7 cells 47 , we found that c-Kit expression was much lower in mouse calvarial osteoblasts compared with osteoclasts. The W sh mutation affects the tissue-specific expression of c-Kit during embryonic development and adulthood 16 . Although c-Kit expression in W sh /W sh osteoclasts was decreased by 35%, its expression in osteoblasts was not altered, indicating that the increased bone formation in W sh /W sh mice was not due to an intrinsic effect in osteoblasts. The fact that calvarial osteoblasts isolated from W sh /W sh mice had increased ALP activity and formed more bone nodules together with an increase in the number of CFU-ALP and CFU-OB without any change in total CFU-F suggests that the increased osteoblast number in bone in vivo resulted from an increase in the number of committed osteoblast precursors. Our finding indicates that c-Kit mutation leads to increased bone formation in W sh /W sh mice through indirect osteoclast-mediated effects. The evidence that bone resorption triggers bone formation suggests that certain coupling factors derived from osteoclasts are responsible for recruiting osteoblasts progenitors to the remodeling site and stimulating bone formation. Our finding that conditioned medium derived from W sh /W sh osteoclast culture increased ALP activity and mineralization in osteoblasts confirmed an increase in osteoclast-secreted osteoanabolic factors. We demonstrated that c-Kit mutation stimulated Wnt10b, a known coupling factor, production, and secretion from osteoclasts. The increase in Wnt10b production in c-Kit mutant osteoclasts, together with the increased osteoblast differentiation induced by W sh /W sh osteoclast-conditioned medium and the increased bone formation in vivo, strengthen the evidence that osteoclasts can enhance bone formation through secreted coupling factors. Binding of Wnt10b to Wnt receptors, LRP-5 and LRP-6, on osteoblasts stimulates new bone formation 48 . Antagonizing Wnt10b blunted the anabolic effects of the osteoclast-conditioned medium in vitro. Therefore, it is likely that Wnt10b is an osteoclast-derived molecule responsible for the enhancement of bone formation in W sh /W sh mice. However, the mechanism by which c-Kit mutation regulates Wnt10b production by osteoclasts remains to be determined. Our findings do not exclude a contribution of matrix-derived growth factors, such as TGF-β 1, released from the bone matrix during bone resorption. Other investigators have shown that TGF-β 1 stimulates Wnt10b production in osteoclasts that enhances the coupling of bone resorption with formation 26 . Further studies are required to address this question. In conclusion, this study is the first to report the importance of c-Kit as a negative regulator of bone turnover and that Wnt10b is a physiologically important osteoclast-secreted molecule that promotes bone formation in c-Kit mutants. Targeting c-Kit may provide a new insight to develop therapeutic intervention for skeletal disorders. Mice were subcutaneously injected with 20 mg/kg calcein (Sigma, St Louis, MO, USA) and 40 mg/kg demeclocycline (Sigma) and the interlabeling periods were 4, 5, and 6 days for 6-, 9-, and 13-week-old mice, respectively. At the end of the experiment, the mice were weighed and anesthetized with isoflurane. Blood samples were collected and centrifuged and the serum was kept at − 80 °C for determination of P1NP and CTX. The seminal vesicles, tibiae, and femora were removed. The right femora and tibiae of W/W v mice were fixed in 70% alcohol for μ CT analysis and bone histomorphometry, respectively. For W sh /W sh mice, the left tibiae were used for μ CT analysis, whereas the right tibiae were analyzed for bone histomorphometry. The left femora of W sh /W sh mice were frozen in liquid nitrogen and stored at − 80 °C until processed for RNA isolation and qPCR analysis. μCT. A three-dimensional reconstruction of bone microarchitecture was performed using a desktop μ CT35 (Scanco Medical) following the recommended guidelines 50 . Cortical bone at the tibial or femoral midshaft and cancellous bone at the proximal tibial metaphysis or femoral distal metaphysis were scanned using a 7-μ m isotropic voxel size, 50 kVp, and 144 μ A. For cortical bone, 86 transverse μ CT slices were evaluated using a threshold at 35% of the maximal gray scale value to assess the total cross-sectional volume (mm Osteoblast differentiation and proliferation and CFU assays. One-day old pups were genotyped by PCR using primer pair P1 (TTTGCACGTGCTAGTTACAC) and P2 (TTAAGATGGCACCCTGCTG) for WT template and primer pair P3 (AGGCTTGCAGCGCATTAT) and P4 (GAGGATTCATAGTTGTTCAATGTCC) for W sh /W sh template 51 . Primary calvarial osteoblasts derived from W sh /W sh mice and their control littermates were plated at 1 × 10 4 cells/well in 12-well plates and cultured in differentiation medium containing α -MEM supplemented with 10% FBS, 100 unit/ml penicillin and 100 μ g/ml streptomycin, 5 mM β -glycerophosphate, 10 μ M dexamethasone, and 50 μ g/ml ascorbic acid. The cells were fixed with 3.7% formaldehyde, and stained for ALP and bone nodules with Fast Blue Alkaline phosphatase (Sigma) and 2% alizarin red (Sigma) on days 7 and 21, respectively. ALP activity and mineralized bone nodules were quantified as previously described 52 . For the DKK1 experiments, WT calvarial osteoblasts were plated at 0.5 × 10 4 cells/well in 24-well plates and cultured with osteoclast-conditioned medium. Recombinant DKK1 (R&D systems) at 0.2 μ g/ml was added to the medium and ALP activity and mineralization bone nodules were determined. For the Wnt10b neutralization experiments, osteoclast-conditioned medium was pretreated with either isotype control or Wnt10b antibody (R&D) at 4 μ g/ml before addition to the osteoblast cultures. The cells were stained with ALP and alizarin red.
Calvarial osteoblasts derived from W sh /W sh mice and controls (7 × 10 3 cells/well) were cultured in 96-well plates for 24 h and exposed to BrdU labeling reagent for 18 h. Osteoblast proliferation was determined by a BrdU incorporation assay per the manufacturer's instructions (Cell Signaling). For CFU assays, calvarial osteoblasts derived from W sh /W sh and WT littermates were plated at 0.25 × 10 4 cells/well in 12-well plates and cultured in differentiation medium. CFU-ALP was determined as ALP-positive colonies on day 7. Mineralized nodules were stained with alizarin red on day 23 for the determination of CFU-OB. The cells were then stained with toluidine blue to determine CFU-F on days 7 and 23 in the same tissue culture plate.
Preparation of osteoclasts.
Bone marrow cells were cultured in α -MEM containing 10%FBS, 100 unit/ml penicillin and 100 μ g/ml streptomycin for 24 h to generate BMMs. The BMMs were then cultured on tissue culture plastic or coverslips in α -MEM for 2 days with 20 ng/ml M-CSF and for an additional 6 days in the same medium with 20 ng/ml M-CSF and 3.3 ng/ml RANKL. Osteoclast-conditioned medium was collected. Multinucleated cells were identified by TRAP staining. For the resorption assay, osteoclasts were generated by culturing BMMs with primary CD1 calvarial osteoblasts in media containing 10 nM 1,25-dihydroxyvitamin D 3 and 1 μ M prostaglandin E 2 on a collagen gel. The collagen was digested with 0.1% collagenase and the osteoclasts were replated onto dentin slices for an additional 48 h to determine their bone-resorbing activity using toluidine blue staining.
For the co-culture studies, calvarial osteoblasts derived from WT and mutants were cultured in α -MEM containing 10% FBS, 100 unit/ml penicillin and 100 μ g/ml streptomycin for 24 h. BMMs were added and cultured in media containing 1,25-dihydroxyvitamin D 3 and prostaglandin E 2 for 5 additional days. TRAP staining was performed.
qPCR. Total RNA was isolated from femora using Trizol reagent according to the manufacturer's instructions (Invitrogen) and purified using an RNeasy Mini kit (Qiagen). The RNA yields were determined spectrophotometrically at 260 nm. One μ g of total RNA was used to synthesize cDNA using SuperScript VILO (Invitrogen). The qPCR was performed at 57 °C for 40 cycles using an iCycler (Biorad) and the results were normalized to GAPDH expression. The primer sequences used are shown in Supplementary Table S5. FACS analysis. Bone marrow and spleen cells were removed and red blood cells were lysed with lysis buffer (eBioscience). The cells were incubated with Alexa Fluor ® 488-conjugated anti-mouse CD11b (eBioscience) for 30 minutes at 4 °C and washed twice with washing buffer. The cells were incubated with PE-conjugated anti-mouse c-Fms (eBioscience) for 30 minutes and washed twice. The stained cells were suspended in PBS and flow cytometry was performed using BD LSRFortessa (Becton Dickinson).
Confocal microscopy. Osteoclasts plated on dentin slices were fixed with 3.7% formaldehyde in phosphate-buffered saline (PBS) for 10 min. Cells were permeabilized in PBS containing 0.05% saponin, 0.1% BSA and 5% normal serum for 30 min, incubated with anti-mouse/rat/human Wnt10b antibody (Santa Cruz) for 1 h, washed, incubated with fluorescent secondary antibody (Alexa Fluor 488), washed again, and mounted in FluorSave (Calbiochem). For actin labeling, the cells were incubated in a 1:40 dilution of rhodamine phalloidin stock solution (Invitrogen) for 1 h and washed with PBS. The nuclei were labeled with TO-PRO-3 (1:1000) in the rhodamine phalloidin solution. Osteoclasts were visualized using a 510 Meta laser scanning confocal microscope (Carl Zeiss) and images were recorded.
Western blot analysis.
Osteoclasts were generated in a 6-well-plate and conditioned medium was collected and concentrated 50-fold using Amicon ultra centrifuge filter units (Millipore). Protein concentration was determined using a BCA protein assay kit (Thermo Scientific). Samples (200 μ g) were resolved using 4-12% Mini-PROTEAN TGX precast gel (Biorad) and transferred to nitrocellulose membranes. The membranes were stained with Ponceau S dye for protein detection then washed in TBST buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, and 0.1% Tween 20) and incubated in TBST buffer containing anti-Wnt10b antibody overnight at 4 °C. The membranes were washed in TBST and incubated with anti-rabbit IgG horseradish peroxidase-conjugated secondary antibody (Promega). The membranes were then washed and developed with an enhanced chemiluminescence detection kit (PerkinElmer, Inc.).
Serum analysis. Serum P1NP and CTX were determined using Rat/Mouse P1NP and RatLaps TM EIA kit, respectively per the manufacturer's protocol (Immunodiagnostic systems). Serum testosterone concentration was measured by enzyme-linked immunosorbent assay (ELISA) per the manufacturer's directions (R&D Systems).
Statistical analysis.
All data are expressed as the mean ± SE. Unpaired Student's t-test was used to compare between 2 groups. Multiple comparisons were determined using one-way ANOVA followed by Fisher's protected least significant difference test. The in vitro experiments were repeated three times. Statistical significance was considered at p < 0.05.
